AbCellera Biologics Inc. (ABCL) — Stock Score Summary

AbCellera Biologics Inc. (ABCL) has a MoatMap StockRank of 45/100 based on Quality (33/100), Value (40/100), and Momentum (59/100) factor scores. The current signal is HOLD. AbCellera Biologics has an interesting drug discovery platform, but it remains unprofitable with highly lumpy royalty revenues and lacks the stable cash flows of a quality compounder.

AbCellera Biologics Inc. is a technology company that utilizes AI-powered single-cell analysis to accelerate antibody discovery and development for drug therapies. Its proprietary platform allows for rapid identification of therapeutic antibodies through partnerships with pharmaceutical companies and academic institutions. AbCellera's innovative approach aims to significantly shorten the drug discovery timeline, offering a competitive advantage in biotech.

Key Financial Metrics

Price$5.30
Market Cap$1.7B
P/E (Forward)-8.85
Price/Book2.06
Return on Equity-14.7%
Return on Invested Capital-15.7%
Debt/Equity14.32
Gross Margin-135.9%
Operating Margin-691.8%
Revenue Growth96.3%
Free Cash Flow$-105M

AbCellera Biologics Inc. operates in the Biotechnology industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is AbCellera Biologics Inc.’s (ABCL) StockRank?
MoatMap’s StockRank for AbCellera Biologics Inc. (ABCL) is 45/100, with a Hold signal. It is a composite of Quality (33), Value (40), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does AbCellera Biologics Inc. have an economic moat?
AbCellera Biologics Inc. (ABCL) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AbCellera Biologics Inc. a buy, hold, or sell?
MoatMap’s current signal for AbCellera Biologics Inc. (ABCL) is Hold, based on a StockRank of 45/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AbCellera Biologics Inc. in?
AbCellera Biologics Inc. (ABCL) operates in the Healthcare sector, specifically the Biotechnology industry (Canada).
Browse all ranked stocksABCL deep dive reportAI ChampionsHow we score stocksSense-check another stock